Adverts

Open Access Articles- Top Results for Iratumumab

Iratumumab

</th></tr>
Iratumumab?
Monoclonal antibody
Type Whole antibody
Source Human
Target CD30
Clinical data
Identifiers
640735-09-7 7pxN
None
KEGG D04612 7pxY
Chemical data
Formula C6358H9830N1682O1992S38
170 kDa
 14pxN (what is this?)  (verify)

Iratumumab is a human monoclonal antibody used in the treatment of oncological diseases such as relapsed refractory CD30-positive lymphoma including Hodgkin's disease.[1]

This drug was developed by Medarex, Inc.

References

  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council – Iratumumab, American Medical Association.


Lua error in package.lua at line 80: module 'Module:Buffer' not found. Lua error in package.lua at line 80: module 'Module:Buffer' not found.